
|
Number 12 -
DECEMBER 2005
Hall SJ, Holman
CD, Platell C, Sheiner H, Threlfall T, Semmens J.
Colorectal cancer surgical care and survival: do private
health insurance, socioeconomic and locational status make a
difference? ANZ J Surg. 2005 Nov;75(11):929-35. Fujii Y, Shimada H, Endo I, Takeda K, Takahashi T, Tanaka K, Togo S. Improvement of prognosis for colorectal metastases by major hepatectomy after portal vein embolization. Hepatogastroenterology. 2005 Nov-Dec;52(66):1792-4. Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, Fujimoto T, Watanabe K, Ogawa K. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology. 2005 Nov-Dec;52(66):1703-6.
Fang WL, Chang SC,
Lin JK, Wang HS, Yang SH, Jiang JK, Chen WC, Lin TC.
Metastatic potential in T1 and T2 colorectal cancer. Blumenthal DS, Fort JG, Ahmed NU, Semenya KA, Schreiber GB, Perry S, Guillory J. Impact of a two-city community cancer prevention intervention on African Americans. J Natl Med Assoc. 2005 Nov;97(11):1479-88. Folsom AR, Hong CP. Magnesium Intake and Reduced Risk of Colon Cancer in a Prospective Study of Women. Am J Epidemiol. 2005 Nov 30; Greenwald B. A comparison of three stool tests for colorectal cancer screening. Medsurg Nurs. 2005 Oct;14(5):292-9; Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005 Nov 16;97(22):1679-87. Menges M, Gartner B, Georg T, Fischinger J, Zeitz M. Cost-benefit analysis of screening colonoscopy in 40- to 50-year-old first-degree relatives of patients with colorectal cancer. Int J Colorectal Dis. 2005 Nov 12;:1-6 Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer. Am J Gastroenterol. 2005 Nov;100(11):2531-9. Fisher DA, Judd L, Sanford NS. Inappropriate colorectal cancer screening: findings and implications. Am J Gastroenterol. 2005 Nov;100(11):2526-30. Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005 Nov;100(11):2519-25. Launoy G, Berchi C. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer] Bull Cancer. 2005 Oct 1;92(10):885-90. French. Ackland SP, Jones M, Tu D, Simes J, Yuen J, Sargeant AM, Dhillon H, Goldberg RM, Abdi E, Shepherd L, Moore MJ. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer. 2005 Nov 28;93(11):1236-43. Bermejo JL, Hemminki K. Familial risk of cancer shortly after diagnosis of the first familial tumor. J Natl Cancer Inst. 2005 Nov 2;97(21):1575-9. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ; American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005 Nov 20;23(33):8512-9.
Yu
B, Tiwari RC, Cronin KA, McDonald C, Feuer EJ.
CANSURV: A Windows program for population-based cancer
survival analysis. Gologan A, Krasinskas A, Hunt J, Thull DL, Farkas L, Sepulveda AR. Performance of the revised Bethesda guidelines for identification of colorectal carcinomas with a high level of microsatellite instability. Arch Pathol Lab Med. 2005 Nov;129(11):1390-7. Dove-Edwin I, Sasieni P, Adams J, Thomas HJ. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ. 2005 Nov 5;331(7524):1047. Aldrighetti L, Castoldi R, Di Palo S, Arru M, Stella M, Orsenigo E, Gavazzi F, Ferla G, Di Carlo V, Staudacher C. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases] Chir Ital. 2005 Sep-Oct;57(5):555-70. Italian Klintrup K, Makinen JM, Kauppila S, Vare PO, Melkko J, Tuominen H, Tuppurainen K, Makela J, Karttunen TJ, Makinen MJ. Inflammation and prognosis in colorectal cancer. Eur J Cancer. 2005 Nov;41(17):2645-54. Hassan C, Gaglia P, Zullo A, Scaccianoce G, Piglionica D, Rossini FP, Morini S. Endoscopic follow-up after colorectal cancer resection: An Italian multicentre study Dig Liver Dis. 2005 Oct 6; Suceveanu AI, Suceveanu A, Dumitru E, Alexandrescu L, Voinea F. The feasibility of FOBT tests in colorectal cancer screening in Dobrogea. Rom J Gastroenterol. 2005 Sep;14(3):213-7.
Menges M,
Fischinger J, Gartner B, Georg T, Woerdehoff D, Maier M,
Harloff M, Stegmaier C, Raedle J, Zeitz M.
Screening colonoscopy in 40- to 50-year-old first-degree
relatives of patients with colorectal cancer is efficient: a
controlled multicentre study. Kutzner N, Hoffmann I, Linke C, Thienel T, Grzegorczyk M, Urfer W, Martin D, Winde G, Traska T, Hohlbach G, Muller KM, Kuhnen C, Muller O. Non-invasive detection of colorectal tumours by the combined application of molecular diagnosis and the faecal occult blood test. Cancer Lett. 2005 Nov 8;229(1):33-41. Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, Rothman N, Hayes RB. Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res. 2005 Sep 1;65(17):8034-41. Bruce WR, Cirocco M, Giacca A, Kim YI, Marcon N, Minkin S. A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation. Br J Cancer. 2005 Sep 19;93(6):639-46. Otani T, Iwasaki M, Inoue M; Shoichiro Tsugane for the Japan Public Health Center-based Prospective Study Group. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Causes Control. 2005 Sep;16(7):839-50. Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM, D'Amico R, Conte PF, Natalini G. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum. 2005 Oct;48(10):1851-7. Anderson JC, Alpern Z, Sethi G, Messina CR, Martin C, Hubbard PM, Grimson R, Ells PF, Shaw RD. Prevalence and risk of colorectal neoplasia in consumers of alcohol in a screening population. Am J Gastroenterol. 2005 Sep;100(9):2049-55. Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG. Prevalence of family history of colorectal cancer in the general population. Br J Surg. 2005 Sep;92(9):1161-4. |